Navigation Links
Asymchem Announces Fall Process Symposium Confirmed List of Speakers
Date:9/4/2009

TEDA TIANJIN, China, Sept. 4 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd., a wholly-owned subsidiary of Asymchem Laboratories Inc., a leading research-based contract manufacturer of API's and intermediates and Drug Products to the pharmaceutical industry, is pleased to issue the final confirmed list of speakers for the upcoming Fall Symposium in Process Chemistry held in Asymchem Life Science in TEDA Tianjin, P.R. China, from October 17-19, 2009.

Company and Academic speakers to present at Asymchem's Fall Process Chemistry Symposium Oct 17-19, 2009:

     No.  Company     Speaker         Title         Topic
     ---  -------     -------         -----         -----
     1    Merck       Joe Armstong    Senior Dir.,  Innovation as the
                                      Process       Driver of Green
                                      Research      Chemistry Advances in
                                                    the Pharmaceutical
                                                    Industry

     2    Lilly       Hannah Yu       Scientist     Development of an
                                                    Efficient
                                                    Palladium-Catalyzed
                                                    Intramolecular
                                                    Carbometalation
                                                    Reaction for the
                                                    Synthesis of a
                                                    Dibenzoxapine
                                                    Containing
                                                    Tetrasubstituted
                                                    Exocyclic Alkene

     3    Pfizer      Yousef          Principal     Evolution of the
                      Hajikarimian    Scientist     manufacturing process
                                                    to UK-369,003-26 / a
                                                    PDE5 inhibitor for
                                                    treatment of multiple
                                                    indications

     4    Pfizer      Matt Birchmeier Physical      Crystallization:
                                      properties    Theory, Methods, and
                                      Scientist     Analyses

     5    Concert     Andy Jones      Senior Dir.,  The Challenge of
                                      Chemistry     Large-scale
                                                    Manufacture of
                                                    Deuterated APIs

     6    Lexicon     Winston Wu      Senior Dir.,  Process Chemistry in a
                                      Chemical      Small Biotech Company:
                                      Development   A Case Study

     7    BMS         Mauricio Futran VP, Process   API and Intermediates
                                      R&D           Outsourcing: The
                                                    Changing Value
                                                    Proposition for
                                                    Suppliers

     8    BMS         Stephen         VP,           Pharmaceutical Analysis
                      Scypinski       Analytical    in the 21st Century:
                                      R&D           New Challenges and New
                                                    Solutions

     9    Lilly       Scott Bradley   Scientist     NMR-based Reaction
                                                    Monitoring: From Small
                                                    Molecules to Biologics

     10   Roche       Yi Ren          Head of Drug  Process Research of a
                                      Supply and    Glucose Kinase
                                      Discovery     Activator for the
                                      Technology    Treatment of Type-II
                                                    Diabetes

     11   University  Richard Hsung   Professor     Total Synthesis of
          of                                        Phomactin A.
          Wisconsin

     12   University  Andy Evans      Professor     New Asymmetric Methods
          of                                        for Heterocyclic
          Liverpool                                 Synthesis - Total
                                                    Synthesis of
                                                    Marinomycin A

     13   North       Muk Sibi        Professor     Chiral Lewis and
          Dakota                                    Bronsted Acid
          State                                     Catalysis:
          University                                Exploration of
                                                    Asymmetric
                                                    Transformations

     14   Swiss       Erick Carreira  Professor     Surprises and
          Federal                                   Discoveries with
          Institute                                 Natural Products
          of
          Technology

     15   West        George          Asst          De Novo Synthesis in
          Virginia    O'Doherty       Professor     Carbohydrate Chemistry
          University

     16   AstraZeneca Andy Wells

     17   Beijing     Xi Zhenfeng     Professor
          University

     18   Nankai      Zhou Qilin      Professor
          University

     19   Tianjin     Sun Yan         Professor
          University

     20   Lanzhou     Wang Rui        Professor
          University

"We are pleased to bring together industrial and academic experts in the field of process chemistry and synthetic organic chemistry for a 3-day event," says Dr. Hao Hong, President and CEO of Asymchem. "The symposium will showcase new developments in the process field and provide a forum of discussion as to the state of the API contract R&D and manufacturing business in China, with a direct view into one of the key suppliers at the forefront."

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Asymchem Announces sFDA Certification for Drug Product Manufacturing
2. Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis
3. Asymchem Announces Opening of High Potency API and Drug Product Facility
4. Neusoft Announces New Releases of Flagship Medical Products
5. Hill-Rom Announces Fourth Quarter 2009 Dividend
6. Health2 Resources Announces News Portal, E-News Brief Focused on Patient Centered Medical Home
7. MDS Announces Special Meeting of Shareholders and Record Date
8. N.C. Governor Perdue Announces Application for $28.1 Million in Broadband Recovery Funding
9. Embla(R) Systems Announces the Acquisition of the Sandman(R) Sleep Diagnostic Business from Covidien(R) - Creating the Worlds Largest Sleep Diagnostic Company
10. Saddle Ranch Productions Announces New Releases
11. Selective Insurance Group Announces Officer Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... ... May 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. No matter ... share its attributes like never before. More than a map, new social marketplace ... stores, strains, products – and for the first time – each other. A social ...
(Date:5/21/2017)... ... May 21, 2017 , ... Dental visits ... six months since you've seen a dentist, it's time for a dental checkup. ... x-rays once per year. , Dental checkups are a relatively easy procedure that ...
(Date:5/19/2017)... ... ... Springfield, Vermont-based law firm of Brady/Callahan has released a new Personal Injury law ... Personal Injury Attorney, " the article offers insight for people who have questions, concerns ... someone is injured due to another person's negligence, they may want to ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 4, 2017  Fortuna Fix Inc. (" Fortuna "), ... first to eliminate the need for embryonic and fetal stem ... neurodegenerative diseases. Fortuna announced today the ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald , ... and Professor James Giordano , PhD. "We ...
(Date:5/4/2017)... 4, 2017  A new tight-tolerance microextrusion medical ... highly-engineered materials, is being launched by Natvar, a ... developed in recent years to service a wide ... applications. More expensive materials such as glass and ... due to their ability to consistently hold tolerances. ...
(Date:5/3/2017)... 3, 2017  West Pharmaceutical Services, Inc. (NYSE: ... injectable drug administration, announced today that Fran ... Services, and Diane Paskiet , Director, Scientific ... focused on West,s expertise in the areas of ... as providing commentary on updated industry guidance. ...
Breaking Medicine Technology: